These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30427871)

  • 1. Deuterium isotope effects in drug pharmacokinetics II: Substrate-dependence of the reaction mechanism influences outcome for cytochrome P450 cleared drugs.
    Sun H; Piotrowski DW; Orr STM; Warmus JS; Wolford AC; Coffey SB; Futatsugi K; Zhang Y; Vaz ADN
    PLoS One; 2018; 13(11):e0206279. PubMed ID: 30427871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme Kinetics and Molecular Docking Studies on Cytochrome 2B6, 2C19, 2E1, and 3A4 Activities by Sauchinone.
    Gong EC; Chea S; Balupuri A; Kang NS; Chin YW; Choi YH
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29498658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deuterium isotope effects on drug pharmacokinetics. I. System-dependent effects of specific deuteration with aldehyde oxidase cleared drugs.
    Sharma R; Strelevitz TJ; Gao H; Clark AJ; Schildknegt K; Obach RS; Ripp SL; Spracklin DK; Tremaine LM; Vaz AD
    Drug Metab Dispos; 2012 Mar; 40(3):625-34. PubMed ID: 22190693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of N-methyl deuteration on metabolism and pharmacokinetics of enzalutamide.
    Jiang J; Pang X; Li L; Dai X; Diao X; Chen X; Zhong D; Wang Y; Chen Y
    Drug Des Devel Ther; 2016; 10():2181-91. PubMed ID: 27462143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic deuterium isotope effects for 7-alkoxycoumarin O-dealkylation reactions catalyzed by human cytochromes P450 and in liver microsomes. Rate-limiting C-H bond breaking in cytochrome P450 1A2 substrate oxidation.
    Kim KH; Isin EM; Yun CH; Kim DH; Guengerich FP
    FEBS J; 2006 May; 273(10):2223-31. PubMed ID: 16649998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidation of R- and S-omeprazole stereoselectively mediated by liver microsomal cytochrome P450 2C19 enzymes from cynomolgus monkeys and common marmosets.
    Uehara S; Kawano M; Murayama N; Uno Y; Utoh M; Inoue T; Sasaki E; Yamazaki H
    Biochem Pharmacol; 2016 Nov; 120():56-62. PubMed ID: 27641812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals.
    Russak EM; Bednarczyk EM
    Ann Pharmacother; 2019 Feb; 53(2):211-216. PubMed ID: 30136594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rapid MS/MS method to assess the deuterium kinetic isotope effect and associated improvement in the metabolic stability of deuterated biological and pharmacological molecules as applied to an imaging agent.
    Murphy RB; Wyatt NA; Fraser BH; Yepuri NR; Holden PJ; Wotherspoon ATL; Darwish TA
    Anal Chim Acta; 2019 Aug; 1064():65-70. PubMed ID: 30982519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic Deuterium Isotope Effects in Cytochrome P450 Reactions.
    Guengerich FP
    Methods Enzymol; 2017; 596():217-238. PubMed ID: 28911772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altering Metabolic Profiles of Drugs by Precision Deuteration 2: Discovery of a Deuterated Analog of Ivacaftor with Differentiated Pharmacokinetics for Clinical Development.
    Harbeson SL; Morgan AJ; Liu JF; Aslanian AM; Nguyen S; Bridson GW; Brummel CL; Wu L; Tung RD; Pilja L; Braman V; Uttamsingh V
    J Pharmacol Exp Ther; 2017 Aug; 362(2):359-367. PubMed ID: 28611092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of CYP3A4 and CYP2C19 in methyl hydroxylated and N-oxidized metabolite formation from voriconazole, a new anti-fungal agent, in human liver microsomes.
    Murayama N; Imai N; Nakane T; Shimizu M; Yamazaki H
    Biochem Pharmacol; 2007 Jun; 73(12):2020-6. PubMed ID: 17433262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The kinetic isotope effect in the search for deuterated drugs.
    Shao L; Hewitt MC
    Drug News Perspect; 2010; 23(6):398-404. PubMed ID: 20697607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of cytochrome P4503A4- and 2D6-catalyzed dehydrogenation of ezlopitant as probed with isotope effects using five deuterated analogs.
    Obach RS
    Drug Metab Dispos; 2001 Dec; 29(12):1599-607. PubMed ID: 11717179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different contributions of cytochrome P450 2C19 and 3A4 in the oxidation of omeprazole by human liver microsomes: effects of contents of these two forms in individual human samples.
    Yamazaki H; Inoue K; Shaw PM; Checovich WJ; Guengerich FP; Shimada T
    J Pharmacol Exp Ther; 1997 Nov; 283(2):434-42. PubMed ID: 9353355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of a deuterium replacement strategy to modulate the pharmacokinetics of 7-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-3-(4-methoxy-2-methylphenyl)-2,6-dimethylpyrazolo[5,1-b]oxazole, a novel CRF1 antagonist.
    Stringer RA; Williams G; Picard F; Sohal B; Kretz O; McKenna J; Krauser JA
    Drug Metab Dispos; 2014 May; 42(5):954-62. PubMed ID: 24616265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of cytochrome P450 mechanism and kinetics using kinetic deuterium isotope effects.
    Higgins L; Bennett GA; Shimoji M; Jones JP
    Biochemistry; 1998 May; 37(19):7039-46. PubMed ID: 9578592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of isatin on protein-protein interactions between cytochrome b5 and cytochromes P450].
    Ershov PV; Yablokov EO; Mezentsev YV; Kalushskiy LA; Florinskaya AV; Veselovsky AV; Gnedenko OV; Gilep AA; Usanov SA; Medvedev AE; Ivanov AS
    Biomed Khim; 2017 Mar; 63(2):170-175. PubMed ID: 28414290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gas uptake studies of deuterium isotope effects on dichloromethane metabolism in female B6C3F1 mice in vivo.
    Andersen ME; Clewell HJ; Mahle DA; Gearhart JM
    Toxicol Appl Pharmacol; 1994 Sep; 128(1):158-65. PubMed ID: 8079349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deuterated driven new chemical entities: An optimistic way to improve therapeutic efficacy.
    Chandra Mouli HM; Vinod A; Kumari S; Tiwari AK; Kathiravan MK; Ravichandiran V; Peraman R
    Bioorg Chem; 2023 Jun; 135():106490. PubMed ID: 37001472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological uses and perspectives of heavy water and deuterated compounds.
    Kushner DJ; Baker A; Dunstall TG
    Can J Physiol Pharmacol; 1999 Feb; 77(2):79-88. PubMed ID: 10535697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.